Clinical Trial Detail

NCT ID NCT04047706
Title Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

malignant glioma

Therapies

BMS-986205 + Nivolumab

BMS-986205 + Nivolumab + Temozolomide

Age Groups: senior adult

No variant requirements are available.